Earnings Per Share
EPS (Basic)
Moderna EPS (Basic) decreased by 61.1% to $-3.40 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 34.9%, from $-2.52 to $-3.40. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows a downward trend with a -30.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityVolatile
First reportedQ1 2019
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher values indicate better earnings performance per share, whereas negative values reflect a net loss per share.
Detailed definition
Basic earnings per share is calculated by dividing the net income available to common shareholders by the weighted-avera...
Peer comparison
Investors compare this against industry peers to assess relative valuation and earnings efficiency on a per-share basis.
Metric ID:
eps_basicHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.93 | $8.27 | $12.06 | $9.09 | $5.55 | $2.67 | $3.85 | $0.20 | -$3.62 | -$9.53 | $0.00 | -$3.07 | -$3.33 | $0.03 | -$2.91 | -$2.52 | -$2.13 | -$0.51 | -$2.11 | -$3.40 |
| QoQ Change | — | +19.3% | +45.8% | -24.6% | -38.9% | -51.9% | +44.2% | -94.8% | <-999% | -163.3% | +100.0% | — | -8.5% | +100.9% | <-999% | +13.4% | +15.5% | +76.1% | -313.7% | -61.1% |
| YoY Change | — | — | — | — | -19.9% | -67.7% | -68.1% | -97.8% | -165.2% | -456.9% | -100.0% | <-999% | +8.0% | +100.3% | — | +17.9% | +36.0% | <-999% | +27.5% | -34.9% |
Range-$9.53 – $12.06
CAGR-13.9%
Avg YoY Growth-283.7%
Median YoY Growth-67.7%
Current Streak2 quarters decline
EPS (Basic) at Other Companies
Frequently Asked Questions
- What is Moderna's eps (basic)?
- Moderna (MRNA) reported eps (basic) of $-3.40 in Q1 2026.
- How has Moderna's eps (basic) changed year-over-year?
- Moderna's eps (basic) decreased by 34.9% year-over-year, from $-2.52 to $-3.40.
- What is the long-term trend for Moderna's eps (basic)?
- Over 4 years (2021 to 2025), Moderna's eps (basic) has grown at a -30.0% compound annual growth rate (CAGR), from $30.31 to $-7.27.
- What does eps (basic) mean?
- The portion of a company's profit allocated to each individual share of common stock.